Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, et al
[1] [3] Common agents include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)with tirzepatide being a dual GIP/GLP-1 receptor agonist rather than a GLP-1-only medication
GLOBAL GLUTATHIONE MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION) TABLE 101
Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on managements current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements